Overexpression of Resistance-Nodulation-Division Efflux Pump Genes Contributes to Multidrug Resistance in <i>Aeromonas hydrophila</i> Clinical Isolates

Abstract

<i>Aeromonas hydrophila</i> is a Gram-negative bacterium that is a critical causative agent of infections in fish and is occasionally responsible for human infections following contact with contaminated water or food. Currently, the extensive use of antibiotics in clinical practice has led to increased number of isolates of multidrug-resistant (MDR) <i>Aeromonas</i> and has posed a serious public health challenge. The efflux pump system is a critical mechanism of antibiotic resistance in most Gram-negative bacteria. However, the role of resistance-nodulation-division (RND)-type efflux pumps in MDR <i>A. hydrophila</i> is not fully understood. We aimed to evaluate the contribution of the RND efflux pump system to MDR <i>A. hydrophila</i> clinical isolates. PCR results indicated a considerable variation in the presence of RND efflux pump genes in clinical isolates compared to that of the environmental reference strain ATCC7966^T. Compared to non-MDR clinical isolates, the expression levels of three putative RND efflux pump genes, AHA0021, AHA1320, and AheB, were significantly elevated in MDR strains. The minimal inhibitory concentrations of piperacillin/tazobactam, imipenem, erythromycin, and polymyxin B were significantly reduced by phenylalanine-arginine β-naphthylamide (PAβN), further supporting the contribution of the RND efflux system in MDR <i>A. hydrophila</i>. We provided evidence supporting the contribution of the RND efflux system to multidrug resistance in <i>A. hydrophila</i> clinical isolates. Further studies are warranted to elucidate the detailed mechanisms that confer intrinsic resistance to antimicrobials in <i>A. hydrophila</i>.